We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioLeap Wins GlaxoSmithKline Contract to Design Novel Lead Compounds for Previously Intractable Targets

News   Sep 09, 2009

 
BioLeap Wins GlaxoSmithKline Contract to Design Novel Lead Compounds for Previously Intractable Targets
 
 
 

RELATED ARTICLES

Detecting Genetically Engineered Organisms in the Wild

News

If a genetically or synthetically engineered organism is released into the environment, how will we know? How can we tell it apart from the millions of microorganisms that exist naturally in the wild? Researchers are now developing a biosecurity tool that can detect engineered microorganisms based on their unique DNA signatures.

READ MORE

New Open-source Solution for the Analysis of High Content Screening Data

News

A new open-source solution for the analysis of high content screening (HCS) data in biomedical research, has been released.

READ MORE

Casting a Spotlight on Cancer Metabolism With Bioluminescence

News

Scientists have invented a new way to quantify - in real-time - glucose metabolism of cancerous tumors by making them bioluminesce.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE